
- Strongest evidence for fat loss
- FDA-approved GLP-1 medicines
- Sermorelin
- Raises growth hormone; body composition evidence is small and short-term
- MOTS-c
- Mouse data; not FDA-approved
- Muscle protection
- Strength training at least 2 days a week, plus enough protein
Why your shape changes after 45
MedlinePlus notes that body fat increases steadily after age 30 and tends to collect around the center of the body and internal organs, while muscle and other lean tissue decline. Men often gain weight until about 55 and women until about 65.
Hormones push in the same direction. Estrogen falls at menopause, which shifts fat toward the abdomen. In men, testosterone often declines gradually. Growth hormone tends to decrease with age, and insulin sensitivity can worsen. The result is a body that holds onto fat more easily and builds muscle more slowly.
Where peptides fit
- GLP-1 medicines (semaglutide, tirzepatide): reduce appetite and improve blood sugar control. Branded versions are FDA-approved for weight management and have large clinical trials behind them.
- Sermorelin: prompts your pituitary to release growth hormone, which affects fat and muscle metabolism. Evidence for meaningful body composition changes in healthy midlife adults is limited to small, short studies.
- MOTS-c: a mitochondrial peptide that improved glucose handling and limited weight gain in mice. Human treatment data are lacking. It isn't FDA-approved, and its compounding status was still under FDA review in October 2026.
- Testosterone therapy and enclomiphene are not peptides, but for men with confirmed low testosterone they can affect muscle and fat, and they're often part of the same conversation.
Protecting muscle is the whole game
When weight comes off quickly, some of it is lean tissue. That matters more in midlife, when muscle is already declining and is closely tied to strength, balance, blood sugar control and independence later on.
The CDC recommends muscle-strengthening activity working all major muscle groups on at least 2 days a week, along with 150 minutes of moderate aerobic activity. During weight loss, progressive strength training is the main signal telling your body to keep muscle. Adequate protein, spread across meals, supplies the material.
The scale is the wrong scoreboard
If you lose 15 pounds and a third of it is muscle, the scale looks good while your strength and metabolism suffer. If you lose 8 pounds of fat and gain some muscle, the scale barely moves while your health improves.
Better measures include waist circumference, how your clothes fit, strength in a few key lifts, and, where available, body composition scans. Blood markers such as A1c, fasting insulin and lipids show the metabolic side of the picture.
The hormone connection
For women in perimenopause or menopause, hormone therapy is used to treat symptoms such as hot flashes, not as a weight-loss treatment. But better sleep and less disruption can make it easier to stay active and consistent. For men with confirmed low testosterone, treatment can help with muscle mass when combined with training.
Checking hormones, thyroid and blood sugar before choosing a peptide helps match the treatment to the cause, rather than layering products on top of an untreated problem.
Safety notes
- GLP-1 medicines: common nausea and other digestive effects; a boxed warning for thyroid C-cell tumors in rodents; risks of pancreatitis and gallbladder problems; not for pregnancy.
- Compounded GLP-1s are not FDA-approved and aren't equivalent to Wegovy or Zepbound.
- Growth hormone-releasing peptides are generally avoided with active cancer and need monitoring of blood sugar.
- Research peptides like MOTS-c lack long-term human safety data.
A simple weekly framework
- Two or three full-body strength sessions, progressing weight or reps over time
- About 150 minutes of moderate activity such as brisk walking or cycling
- Protein at every meal rather than mostly at dinner
- A consistent sleep window of at least 7 hours
- A monthly check of waist size and a few key lifts instead of daily weigh-ins
How HealifyMD approaches body composition
Your clinician reviews your history, goals and labs (priced separately), then discusses options that fit. Listed prices include compounded semaglutide injection from $299/month, compounded tirzepatide injection from $399/month, sermorelin ODT from $199/month and MOTS-c from $275/month, all confirmed at your eligibility review. Whatever the plan, expect guidance on protein and strength training and follow-up to adjust as you go.
If you're on a GLP-1 medicine and losing weight quickly, tell your clinician if strength drops noticeably; slowing the pace or adjusting the dose can help protect muscle.
Common questions
Which peptides help with body composition?
GLP-1 medicines have the strongest evidence for fat loss. Sermorelin and MOTS-c are promoted for body composition but have limited human data.
Will I lose muscle while losing weight?
Some lean mass loss is common, especially with rapid weight loss. Strength training and adequate protein help protect it.
Do peptides replace diet and training?
No. They can make changes easier, but training and nutrition drive whether lost weight is mostly fat.
Could hormones be affecting my body composition?
Yes. Menopause, low testosterone and insulin resistance all shift fat toward the middle and make muscle harder to keep.
Is this a fast way to lose weight?
Sustainable fat loss is measured in months. Faster loss often means more muscle loss and more side effects.
How should I measure progress?
Track waist size, strength and how clothes fit alongside weight, and recheck metabolic labs with your clinician.
Is MOTS-c FDA-approved?
No. It isn't approved for any use, and evidence in people is very limited.
Sources
We cite government agencies, professional societies and peer-reviewed research. See our editorial policy.
- Aging Changes in Body ShapeMedlinePlus (U.S. National Library of Medicine)
- Aging Changes in Hormone ProductionMedlinePlus (U.S. National Library of Medicine)
- Adult Activity: An OverviewCenters for Disease Control and Prevention
- Semaglutide InjectionMedlinePlus (U.S. National Library of Medicine)
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight LossU.S. Food and Drug Administration
- July 23–24, 2026 Meeting of the Pharmacy Compounding Advisory CommitteeU.S. Food and Drug Administration